Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Prostate Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 64 articles: HTML format

Single Articles

July 2008
1. ATTARD G , Clark J, Ambroisine L, Mills IG, et al
   Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   June 2008
2. STOEHR R , Hitzenbichler F, Kneitz B, Hammerschmied CG, et al
   Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. NAROD SA , Neuhausen S, Vichodez G, Armel S, et al
   Rapid progression of prostate cancer in men with a BRCA2 mutation.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. KAKIZAKI M , Inoue K, Kuriyama S, Sone T, et al
   Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. MYLES P , Evans S, Lophatananon A, Dimitropoulou P, et al
   Diagnostic radiation procedures and risk of prostate cancer.
   Br J Cancer. 2008;98:1852-6.
   PubMed     Related articles    Abstract available
   
   
   May 2008
6. REAM E , Quennell A, Fincham L, Faithfull S, et al
   Supportive care needs of men living with prostate cancer in England: a survey.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   April 2008
7. MELIA J , Coulson P, Coleman D, Moss S, et al
   Urological referral of asymptomatic men in general practice in England.
   Br J Cancer. 2008;98:1176-81.
   PubMed     Related articles    Abstract available
   
   
   
8. RENNEL E , Waine E, Guan H, Schuler Y, et al
   The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.
   Br J Cancer. 2008;98:1250-7.
   PubMed     Related articles    Abstract available
   
   
   
9. ALLEN NE , Key TJ, Appleby PN, Travis RC, et al
   Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
10. MCCALL P , Gemmell LK, Mukherjee R, Bartlett JM, et al
    Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients.
    Br J Cancer. 2008;98:1094-101.
    PubMed     Related articles    Abstract available
    
    
    
11. EWALD JA , Desotelle JA, Almassi N, Jarrard DF, et al
    Drug-induced senescence bystander proliferation in prostate cancer cells in vitro and in vivo.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. KHANDELWAL A , Gediya LK, Njar VC
    MS-275 synergistically enhances the growth inhibitory effects of RAMBA VN/66-1 in hormone-insensitive PC-3 prostate cancer cells and tumours.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
13. HURT EM , Kawasaki BT, Klarmann GJ, Thomas SB, et al
    CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
    Br J Cancer. 2008;98:756-65.
    PubMed     Related articles    Abstract available
    
    
    
14. NORMAN G , Dean ME, Langley RE, Hodges ZC, et al
    Parenteral oestrogen in the treatment of prostate cancer: a systematic review.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. WANG W , Wang H, Rayburn ER, Zhao Y, et al
    20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
16. DEAN JP , Nelson PS
    Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis.
    Br J Cancer. 2008;98:245-9.
    PubMed     Related articles    Abstract available
    
    
    
17. SPRENGER CC , Plymate SR, Reed MJ
    Extracellular influences on tumour angiogenesis in the aged host.
    Br J Cancer. 2008;98:250-5.
    PubMed     Related articles    Abstract available
    
    
    
18. WEICHERT W , Roske A, Gekeler V, Beckers T, et al
    Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. COX RA , Sundar S
    Re-induction of hormone sensitivity to diethylstilboestrol in androgen refractory prostate cancer patients following chemotherapy.
    Br J Cancer. 2008;98:238-9.
    PubMed     Related articles   
    
    
    
20. SHAMASH J , Davies A, Ansell W, McFaul S, et al
    A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer.
    Br J Cancer. 2008;98:22-4.
    PubMed     Related articles    Abstract available
    
    
    
21. WAXMAN J , Ngan S
    Androgen resistance in prostate cancer.
    Br J Cancer. 2008;98:1.
    PubMed     Related articles   
    
    
    
22. MITRA A , Fisher C, Foster CS, Jameson C, et al
    Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. KUMANO M , Miyake H, Kurahashi T, Yamanaka K, et al
    Enhanced progression of human prostate cancer PC3 cells induced by the microenvironment of the seminal vesicle.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
24. NAITO M , Komohara Y, Ishihara Y, Noguchi M, et al
    Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.
    Br J Cancer. 2007;97:1648-54.
    PubMed     Related articles    Abstract available
    
    
    
25. NEWMAN SP , Foster PA, Ho YT, Day JM, et al
    The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.
    Br J Cancer. 2007;97:1673-82.
    PubMed     Related articles    Abstract available
    
    
    
26. STEINBILD S , Mross K, Frost A, Morant R, et al
    A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.
    Br J Cancer. 2007;97:1480-5.
    PubMed     Related articles    Abstract available
    
    
    November 2007
27. SACCA P , Meiss R, Casas G, Mazza O, et al
    Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. GALLI L , Fontana A, Galli C, Landi L, et al
    Phase II study of sequential chemotherapy with docetaxel-estramustine followed by mitoxantrone-prednisone in patients with advanced hormone-refractory prostate cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
29. LE FRANCOIS BG , Maroun JA, Birnboim HC
    Expression of thymidylate synthase in human cells is an early G(1) event regulated by CDK4 and p16INK4A but not E2F.
    Br J Cancer. 2007;97:1242-50.
    PubMed     Related articles    Abstract available
    
    
    October 2007
30. NAM RK , Sugar L, Yang W, Srivastava S, et al
    Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
31. CARLES J , Font A, Mellado B, Domenech M, et al
    Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    September 2007
32. NONOMURA N , Takayama H, Nishimura K, Oka D, et al
    Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. ZVEREFF V , Wang JC, Shun K, Lacoste J, et al
    Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. YOSHIMOTO M , Cunha IW, Coudry RA, Fonseca FP, et al
    FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.
    Br J Cancer. 2007;97:678-85.
    PubMed     Related articles    Abstract available
    
    
    August 2007
35. ANDREN O , Fall K, Andersson SO, Rubin MA, et al
    MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. AGALLIU I , Karlins E, Kwon EM, Iwasaki LM, et al
    Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
37. CHENG I , Liu X, Plummer SJ, Krumroy LM, et al
    COX2 genetic variation, NSAIDs, and advanced prostate cancer risk.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
38. TAM L , McGlynn LM, Traynor P, Mukherjee R, et al
    Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
39. BENITEZ DA , Pozo-Guisado E, Clementi M, Castellon E, et al
    Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
40. PERRY AS , Loftus B, Moroose R, Lynch TH, et al
    In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. YATES CC , Shepard CR, Stolz DB, Wells A, et al
    Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. DUDDERIDGE TJ , McCracken SR, Loddo M, Fanshawe TR, et al
    Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    March 2007
43. COMSTOCK CE , Revelo MP, Buncher CR, Knudsen KE, et al
    Impact of differential cyclin D1 expression and localisation in prostate cancer.
    Br J Cancer. 2007;96:970-9.
    PubMed     Related articles    Abstract available
    
    
    
44. FEDIDA S , Fishman D, Suzlovich Z, Argov S, et al
    Impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site.
    Br J Cancer. 2007;96:980-5.
    PubMed     Related articles    Abstract available
    
    
    
45. FOSTER C , Watson M, Eeles R, Eccles D, et al
    Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up.
    Br J Cancer. 2007;96:718-24.
    PubMed     Related articles    Abstract available
    
    
    
46. HEANEY RP
    Calcium, dairy, and prostate cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles   
    
    
    
47. LEE IM , Sesso HD
    Reply: Calcium, dairy, and prostate cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles   
    
    
    February 2007
48. FORGET MA , Turcotte S, Beauseigle D, Godin-Ethier J, et al
    The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types.
    Br J Cancer. 2007;96:646-53.
    PubMed     Related articles    Abstract available
    
    
    January 2007
49. RUKIN NJ , Zeegers MP, Ramachandran S, Luscombe CJ, et al
    A comparison of sunlight exposure in men with prostate cancer and basal cell carcinoma.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. ZHU T , Guo J, Collins L, Kelly J, et al
    Phellinus linteus activates different pathways to induce apoptosis in prostate cancer cells.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. GEORGITSI M , Karhu A, Winqvist R, Visakorpi T, et al
    Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers.
    Br J Cancer. 2007;96:352-6.
    PubMed     Related articles    Abstract available
    
    
    
52. VERSCHOYLE RD , Greaves P, Cai H, Edwards RE, et al
    Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis.
    Br J Cancer. 2007;96:248-54.
    PubMed     Related articles    Abstract available
    
    
    
53. TORRING N , Borre M, Sorensen KD, Andersen CL, et al
    Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. MAATTANEN L , Hakama M, Tammela TL, Ruutu M, et al
    Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.
    Br J Cancer. 2007;96:56-60.
    PubMed     Related articles    Abstract available
    
    
    
55. LEVY-LAHAD E , Friedman E
    Cancer risks among BRCA1 and BRCA2 mutation carriers.
    Br J Cancer. 2007;96:11-5.
    PubMed     Related articles    Abstract available
    
    
    
56. BERGH J , Marklund I, Gustavsson C, Wiklund F, et al
    No link between viral findings in the prostate and subsequent cancer development.
    Br J Cancer. 2007;96:137-9.
    PubMed     Related articles    Abstract available
    
    
    
57. LEGRIER ME , Oudard S, Judde JG, Guyader C, et al
    Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
58. PROWATKE I , Devens F, Benner A, Grone EF, et al
    Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
59. LAMY P , Andersen CL, Dyrskjot L, Torring N, et al
    Are microRNAs located in genomic regions associated with cancer?
    Br J Cancer. 2006;95:1415-8.
    PubMed     Related articles    Abstract available
    
    
    
60. KOH KA , Sesso HD, Paffenbarger RS Jr, Lee IM, et al
    Dairy products, calcium and prostate cancer risk.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
61. CUZICK J , Fisher G, Kattan MW, Berney D, et al
    Long-term outcome among men with conservatively treated localised prostate cancer.
    Br J Cancer. 2006;95:1186-94.
    PubMed     Related articles    Abstract available
    
    
    October 2006
62. ENGERS R , Mueller M, Walter A, Collard JG, et al
    Prognostic relevance of Tiam1 protein expression in prostate carcinomas.
    Br J Cancer. 2006;95:1081-6.
    PubMed     Related articles    Abstract available
    
    
    September 2006
63. METCALFE C , Lane JA, Hamdy F, Neal D, et al
    A model of the natural history of screen-detected prostate cancer.
    Br J Cancer. 2006;.
    PubMed     Related articles   
    
    
    July 2006
64. MORRIS JK , George LM, Wu T, Wald NJ, et al
    Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies.
    Br J Cancer. 2006;95:112-7.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: